J. Clin. Invest. 1992, 90, 1958-1965
228 HALLE M., BERG A., VON STEIN T., BAUMSTARK W., KONIG
D., KEUL J. Lipoprotein(a) in endurance athletes, power athletes, and sedentary
controls. Med. Sci. Sports Exerc. 1996, 28, 962-966
238 LOBO R., NOTELOVITZ M., BERNSTEIN L., KHAN F., ROSS
R..
Lp(a) lipoprotein: relationship to cardiovascular disease
risk factors, exercice and estrogen. Amer. J. Obstet. Gynecol. 1992, 166,
1182-1190
231 PONJEE G., JANSSEN E., VAN WERSCH J.
Long-term physical exrecice and lipoprotein(a) levels in
a previously sedentary male and female population.
Ann. Clin. Biochem. 1995, 32, 181-185
232 HOLME L., URDAL P., ANDERSSEN S., HJERMANN I.
Exercice-induced increase in lipoprotein(a).
Atheroscl. 1996, 122, 97-104
233 PARRA H.J., PUCHOIS P., DEMARQUILLY C., FRUCHART
J-C.
Analyse multivariée d'indicateurs biologiques de
consommation excessive d'alcool. Intétêt des paramètres
lipoprotéiques.
Path. Biol. 1987, 35, 1230-1234
234 STEINMETZ J., TARALLO P., FOURNIER B., JAID M., CACES
S. et al Valeurs de référence de la lipoprotéine(a) dans
une population Française. Presse Med. 1994, 23, 1695-1698
235 JENNER J.L., ORDOVAS J.M., LAMON-FAVA S., SCHAEFER
M.M., WILSON P.W. et al. Effects of age, sex, and menopausal status on plasma
lipoprotein(a) levels.
The Framingham Offspring Study. Circulation 1993, 87,
1135-1141
236 DELARUE J., HUSSON M., SCHELLENBERG F., TICHET J.,
VOL S. et al Serum lipoprotein(a) [Lp(a)] in alcoholic men : effect of
withdrawal.
Alcohol 1996, 13, 309-314
237 SIEKMEIER R., MARZ W., KRONENBERGER H., SEIFFERT U.,
GROB W.
Effects of cigarette smoking on plasma lipids,
apolipoproteins, and lipoprotein(a) in healthy subjects. Clin. Chem. 1994, 40,
1350-1351
238 RODRIGUEZ REGUERO J., IGLESIAS CUBERO G., MARTINEZ
CELADA M.? FUEYO J. et al. Interrelationships between lipoprotein(a) and other
cardiovascular risk factors.
Cardiology 1995, 86, 432-435
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 258/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
239 MASAREI J.R., ROUSE I.L., LYNCH W.J., ROBERTSON K. et
al.
Effects of a lacto-ovo vegetarian diet on serum
concentrations of cholesterol, triglyceride, HDL-C, HDL2-C, HDL3-C,
apoprotein-B and Lp(a).
Am. J. Clin. Nutr. 1984, 40, 468-479
240 BERG SCHMIDT E., DALBY KRISTENSEN S., DE CATERIAN R.,
ILLINGWORTH D.
The effects of n-3 fatty acids on plasma lipids and
lipoproteins and other cardiovascualr risk factors in patients with
hyperlipidemia.
Atheroscl. 1993, 103, 107-121
241 CORSETTI J., STERRY J., SPARKS J., SPARKS C.,
WEINTRAUB M.
Effect of weight loss on serum lipoprotein(a)
concentrations in an obese population. Clin. Chem. 1991, 37,
1191-1195
242 ZECHNER R., DESOYE G., SCHWEDITSCH M., PFEIFFER K.,
KOSTNER G. Fluctuations of plasma lipoprotein-A concentrations during pregnancy
and post-partum. Metabolism 1986, 35, 333-336
243 BERG K., ROALD B., SANDE H.
High Lp(a) lipoprotein level in maternal serum may
interfere with placental circulation and cause fetal growth
retardation.
Clin. Genet. 1994, 46, 52-56
244 HUSBY H., ROALD B., SCHJETLEIN R., NESHEIM B-I., BERG
K.
High levels of Lp(a) lipoprotein in a family with cases
of severe pre-eclampsia. Clin. Genet. 1996, 50, 47-49
245 LEERINK C.B., DE VRIES C.V., VAN DER KLIS
F.R.
Elevated levels of serum lipoprotein(a) and
apolipoprotein(a) phenotype are not related to pre-eclampsia.
Acta Obstet. Gynecol. Scand. 1997, 76,
625-628
246 MENDOZA S., VELASQUEZ E., OSONA A., HAMER
T., GLUECK J. Postmenopausal cyclic estrogen-progestin therapy lowers
lipoprotein(a). J. Lab. Clin. Med. 1994, 123, 837-841
247 KIM C., JANG C., CHO D., MIN Y.
Affects of hormone replacement therapy on lipoprotein(a)
and lipids in postmenopausal women. Arterioscler. Thromb. 1994, 14,
275-281
245 HENRIKSSON P., ANGELIN B., BERGLUND L.
Hormonal regulation of serum Lp(a) levels.
Opposite effects after estrogen treatment and
orchidectomy in males with prostatic carcinoma. J. Clin. Invest. 1992, 89,
1166-1171
249 MARCOVINA S.M., LIPPI G., BAGATELL C., BREMMER
W.J.
Testosterone-induced suppression of lipoprotein(a) in
normal men: relation to basal lipoprotein(a) level.
Atherosclerosis 1996, 122, 89-95
250 ALBERS J., TAGGART H., APPLEBAUM-BOWDEN D., HAFFNER
S., CHESTNUT C. et al Reduction of lecithin-cholesterol acyltransferase,
apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid
stanazolol.
Biochim. Biophys. Acta 1984, 795, 293-296
251 MAEDA S., ABE A.., SEISHIMA M., MAKINO K., NOMA A. et
al Transient changes of serum lipoprotein(a) as an acute phase protein.
Atherosclerosis 1989, 78, 145-150
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 259/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
252 MIN W., LEE J.A., HUH J.W.
Relation between lipoprotein(a) concentrations in
patients with acute-phase response and risk analysis for coronary heart
disease.
Clin. Chem. 1997, 43, 1891-1895
253 BIHARI-VARGA M., GRUBER E., ROTHENDER M., ZECHNER R.,
KOSTNER G.
Interaction of lipoprotein Lp(a) and low density
lipoprotein with glycoaminoglycans from human aorta. Arteriosclerosis 1988, 8,
851-857
254 GONZALES-GRONOW M., EDELBERG J., PIZZO S.
Further caracterization of the cellular plasminogen
binding dite : evidence that plasminogen 2 and lipoprotein(a) compete for the
same site.
Biochemistry 1989, 28, 2374-2377
255 HAJJAR K., GAVISH D., BRESLOW J., NACHMAN
R.
Lipoprotein(a) modulation of endothelial cell surface
fibrinolysis and its potential role in atherosclerosis.
Nature 1989, 339, 303-305
256 MILES L. FLESS G., LEVIN E., SCANU A., PLOW
E.
A potential basis for the thrombotic risk associated with
lipoprotein(a). Nature 1989, 339, 301-303
257 LOSCALZO J., WEINFELD M., FLESS G., SCANU A.
Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis
1990, 10, 240-245
258 CHAPMAN M.J., HUBY T., NIGON F., THILLET J.
Lipoprotein(a) : implication in atherothrombosis. Atherosclerosis 1994, 110
Suppl :S69-S75.
258 HERVIO L., CHAPMAN J., THILLET J., LOYAU S.,
ANGLES-CANO E.
Does apolipoprotein(a) heterogeneity influence
lipoprotein(a) effects on fibrinolysis ? Blood 1993, 82, 392-397
268 EDELBERG J., GONZALES-GRONOW M., PIZZO S.
Lipoprotein(a) inhibition of plasminogen activation by
tissue-type plasminogen activator. Thrombosis Research 1990, 57,
155-162
261 LEVIN E.G., MILES L.A., FLESS G.M., SCANU A.M.,
BAYHAM P. et al.
Lipoproteins inhibit the secretion of tissue plasminogen
activatior from human endothelial cells. Arteriosclr. Thromb. 1994, 14,
438-442
262 EDELBERG J., PIZZO S.
Lipoprotein(a) regulates plasmin generation and
inhibition. Chem. Phys. Lipids 1994, 67/67, 363-368
263 LIU J., HARPEL P., PANNELL R., GUREWICH
V.
Lipoprotein(a) : a kinetic study of its influence on
fibrin-dependent plasminogen activation by prourokinase ou tissue plasminogen
activator.
Biochemistry 1993, 32, 9694-9700
264 HALVORSEN S., SKJONSBERG O., RUYTER R., GODAL H. Does
Lp(a) lipoprotein inhibit the fibrinolytic system ?
Thrombosis Research 1992, 68, 223-232
265 LIU J., HARPEL P., GUREWICH V.
Fibrin-bound lipoprotein(a) promotes plasminogen binding
but inhibits fibrin degradation by plasmin. Biochemistry 1994, 33,
2554-2560
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 260/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
266 TERRES W., KREWITT M., HAMM C.
Effects of lipoprotein(a) on in vitro lysis of whole
blood thrombi from healthy volunteers.
Thrombosis research 1993, 69, 479-487
267 OSHIMA S., UCHIDA K., YASU T., UNO K. et
al.
Transient increase of plasma lipoprotein(a) in patients
with unstable angina pectoris. Does lipoprotein(a) alter fibrinolysis
?
Arterioscler. Thrombos. 1991, 11, 1772-1777
268 GARCIA-FRADE L., ALVAREZ J., RAYO I., TORRADO M.,
LASUNCION M. et al.
Fibrinolytic parameters and lipoprotein(a) levels in
plasma of patients with coronary artery disease. Thrombosis Research 1991, 63,
407-418
268 MARZ W., TROMMLITZ M., SCHARRER I., GROB
W.
Apolipoprotein(a) concentrations are not related to the
risk of venous thrombosis. Blood Coag. Fibrinol. 1991, 2, 595-599
270 GRAINGER D.J., KEMP P.R., LIU A.C., LAWN
R.M., METCALFE J.C.
Activation of transforming growth factor R is
inhibited in transgenic apolipoprotein(a) mice. Nature 1994, 370,
460-462
271 HARRIS E.D.
Lipoprotein(a) : a predictor of atherosclerotic disease.
Nutr. Rev. 1997, 55, 61-64
272 BIESIEGEL U., NIENDORF A., WOLF K., REBLIN T., RATH
M. Lipoprotein(a) in the arterial wall.
Eur. Heart J. 1990, 11 (Supp E), 174-183
273 BYRNE C., WILD S.
Lipoprotein(a) in health and disease. Br. J. Clin. Pract.
1994, 48, 206-211
274 BERG K., RO O.
Lp(a) lipoprotein level and longevity. Ann. Genet. 1991,
34, 264-269
276 WALTON K., HITCHENS J., MAGNANI H., KHAN
M.
A study of methods of identification and estimation of
Lp(a) lipoprotein and of its significance in health, hyperlipidemia and
atherosclerosis.
Atherosclerosis 1974, 20, 323-346
276 MOLINARI E., PICHLER P., KREMPLER F., KOSTNER
G.
A rapid screening method for pathological lipoprotein
Lp(a) concentrations by counterimmunoelectrophoresis.
Clin. Chim. Acta 1983, 128, 373-378
277 VAN BIERVLIET J-P., MICHIELS G., ROSSENEU
M.
Quantification of lipoprotein(a) in dried blood spots and
screening for above-normal lipoprotein(a) concentrations in
newborns.
Clin. Chem. 1991, 37, 706-708
278 BRUCKERT E., TRUFFERT J., DE GENNES J-L., LAGARDE
J-P., BERNARD C. et al Does electrophoresis reliably screen for high serum
lipoprotein Lp(a) ?
Clin. Chim. Acta 1990, 188, 71-78
278 FIEVET C., BELLON F., BRINGARD A., FRUCHART J-C.
Detection of Lp(a) on agarose gel.
Ann. Biol. Clin. 1993, 51, 533 (Poster 564)
Thèse Docteur Pharmacie La lipoprotéine Lp(a) :
son intérêt dans l'interprétation du bilan lipidique Dr
GUIMONT MC 261/271 Lipides, Lipoprotéine (a),
Hyperlipoprotéinémie, Athérosclérose, Lipids,
Lipoprotein, Lpa, Hyperlipoproteinemia, Atherosclerosis
280 MOULIN S., FRUCHART J-C., DEWAILLY P.,
SEZILLE G.
Elestrophorèse de lipoprotéines
sériques sur plaque de gel de polyacrylamide-agarose, en gradient
discontinu d'acrylamide.
Clin. Chim. Acta 1979, 91, 159-163
281 MORDELET E., MOREAU N., MAINARD F.
Limits of lipoprotein Lp(a) detection by polyacrylamide
gel electrophoresis in dicontinuous gradient. Scand J. Clin. Lab Invest. 1990,
50, 917-918
282 UTERMANN G., DUBA C., MENZEL H.
Genetics of the quantitative Lp(a) lipoprotein trait. II.
Inheritance of Lp(a) glycoprotein phenotypes. Hum. Genet. 1988, 78,
47-50
283 FARRER M. GAME F., ADAMS P., LAKER M. ALBERTI
K.
A simple, sensitive technique for classification of
apolipoprotein(a) isoforms by dodecyl sulphate polyacrylamide gel
electrophoresis.
Clin. Chim. Acta 1992, 207, 215-225
284 ABE A., NOMA A., ITAKURA H.
Lipoprotein(a) phenotyping using a computerized micro
scale and phenotype frequencies in a healthy Japanese population.
Clin. Chim. Acta 1993, 219, 149-157
288 HUANG C., KRAFT H., GREGG R.
Modified immunoblotting technique for phenotyping
lipoprotein(a). Clin. Chem. 1991, 37, 576-578
286 ALBERS J., MARCOVINA S., LODGE M.
The unique Lp(a) : properties and immunochemical
measurement. Clin. Chem. 1990, 36, 2019-2026
287 ALBERS J., HAZZARD R.
Immunochemical quantification of human plasma Lp(a).
Lipids 1974, 9, 15-26
288 DAGEN M., PACKARD C., SHEPERD J.
A comparison of commercial kits for the measurement of
lipoprotein(a). Ann. Clin. Biochem. 1991, 28, 359-364
289 LAURELL C-B.
Electroimmuno Assay
Scand. J. Clin. Lab. 1972, 29, suppl. 124,
21-37
290 LEVINE D., SLOAN B., LORENZ J.,
HEINZERLING R.
Automated measurement of lipoprotein(a) by
immunoturbidimetric assay. Int. J. Clin. Lab. Res. 1992, 22,
173-178
291 GILLERY P., ARTHUIS P., CUPERLIER C.,
CIRCAUD R. Rate nephelometric assay of serum lipoprotein(a).
Clin. Chem. 1993, 39, 503-508
292 VU-DAC N., CHEKKOR A., PARRA H., DUTHILLEUL P.,
FRUCHART J-C. Latex immunoassay of human serum Lp(a) lipoprotein.
| 
